|

HSCT with Non-TBI Regimen Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Hematopoietic Stem Cell Transplantation

Pipeline

Phase 2: 1

Top Sponsors

  • Masonic Cancer Center, University of Minnesota1

Indications

  • Acquired Bone Marrow Failure Syndromes1
  • Natural Killer Cell Malignancies1
  • MRD Positive Leukemia1
  • Biphenotypic/Undifferentiated/Prolymphocytic Leukemias1
  • High Grade Non-Hodgkin's Lymphoma, Adult1

Minneapolis, Minnesota1 trial

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Masonic Cancer Center at University of Minnesota

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.